Rockwell Medical, Inc.
RMTI
$0.80
-$0.04-4.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,007.08% | -346.28% | 56.01% | 96.86% | 94.31% |
| Total Depreciation and Amortization | 0.55% | 0.09% | -0.91% | 18.86% | 50.97% |
| Total Amortization of Deferred Charges | -16.90% | -69.69% | -69.88% | -76.09% | -61.52% |
| Total Other Non-Cash Items | 3.30% | 22.07% | 12.96% | 4.22% | -3.15% |
| Change in Net Operating Assets | -5.63% | -48.82% | 84.31% | 51.62% | 78.92% |
| Cash from Operations | -115.68% | -163.30% | 173.87% | 139.10% | 144.65% |
| Capital Expenditure | 46.39% | -29.14% | -67.98% | -236.33% | -255.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -107.57% | -108.57% | -193.40% | -191.33% | -140.16% |
| Cash from Investing | -75.59% | -87.85% | 2.34% | 44.28% | -59.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.91% | 55.20% | 61.93% | 64.20% | 65.74% |
| Issuance of Common Stock | -23.23% | 54.91% | -57.91% | -37.61% | -31.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -45.55% | -142.43% | -49,900.00% | -41,200.00% | -32,480.00% |
| Cash from Financing | -42.13% | 112.45% | -74.40% | -47.44% | -35.21% |
| Foreign Exchange rate Adjustments | -- | 66.67% | 33.33% | -400.00% | -25.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -174.13% | -72.22% | -78.68% | 211.69% | 696.87% |